90 related articles for article (PubMed ID: 9571369)
1. Antibodies to GAD in elderly patients with previously diagnosed NIDDM.
Fukui M; Nakamura N; Nakano K; Sawada M; Aoji O; Obayashi H; Shigeta H; Kondo M
Diabetes Care; 1998 Apr; 21(4):675-6. PubMed ID: 9571369
[No Abstract] [Full Text] [Related]
2. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
Takeda H; Kawasaki E; Shimizu I; Konoue E; Fujiyama M; Murao S; Tanaka K; Mori K; Tarumi Y; Seto I; Fujii Y; Kato K; Kondo S; Takada Y; Kitsuki N; Kaino Y; Kida K; Hashimoto N; Yamane Y; Yamawaki T; Onuma H; Nishimiya T; Osawa H; Saito Y; Makino H;
Diabetes Care; 2002 Jun; 25(6):995-1001. PubMed ID: 12032105
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic significance of antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary oral hypoglycemic agents failure.
Fukui M; Nakano K; Maruya E; Saji H; Ohta K; Ohta M; Obayashi H; Mori H; Kajiyama S; Wada S; Shigeta H; Kitagawa Y; Nakamura N; Kondo M
Clin Immunol Immunopathol; 1997 Nov; 85(2):182-6. PubMed ID: 9344701
[TBL] [Abstract][Full Text] [Related]
4. HLA typing and immunological characterization of young-onset diabetes mellitus in a Hong Kong Chinese population.
Kelly MA; Chan JC; Heward J; Mijovic CH; Zimmet PZ; Yeung VT; Cockram C; Barnett AH
Diabet Med; 2001 Jan; 18(1):22-8. PubMed ID: 11168337
[TBL] [Abstract][Full Text] [Related]
5. HLA-associated cellular response to GAD in type 2 diabetes with antibodies to GAD.
Fukui M; Nakamura N; Nakano K; Kajiyama S; Matsuo S; Obayashi H; Ohta M; Shigeta M; Shigeta H; Kitagawa Y; Kondo M
Endocr J; 2000 Dec; 47(6):753-61. PubMed ID: 11228050
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
[TBL] [Abstract][Full Text] [Related]
7. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
[TBL] [Abstract][Full Text] [Related]
8. HLA-DRB1 alleles contribute to determining the prognosis of Japanese diabetes mellitus positive for antibodies to glutamate decarboxylase.
Fukui M; Nakano K; Nakamura N; Maruya E; Saji H; Obayashi H; Ohta K; Ohta M; Mori H; Kajiyama S; Wada S; Kida Y; Kosaka K; Deguchi M; Shigeta H; Kitagawa Y; Kondo M
J Clin Immunol; 1998 Jan; 18(1):89-92. PubMed ID: 9475358
[TBL] [Abstract][Full Text] [Related]
9. GAD antibodies seldom disappear in slowly progressive IDDM.
Kobayashi T; Nakanishi K; Okubo M; Murase T; Kosaka K
Diabetes Care; 1996 Sep; 19(9):1031. PubMed ID: 8875105
[No Abstract] [Full Text] [Related]
10. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A
J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.
Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y
Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927
[TBL] [Abstract][Full Text] [Related]
12. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
Niskanen LK; Tuomi T; Karjalainen J; Groop LC; Uusitupa MI
Diabetes Care; 1995 Dec; 18(12):1557-65. PubMed ID: 8722051
[TBL] [Abstract][Full Text] [Related]
13. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes.
Banerji MA; Chaiken RL; Huey H; Tuomi T; Norin AJ; Mackay IR; Rowley MJ; Zimmet PZ; Lebovitz HE
Diabetes; 1994 Jun; 43(6):741-5. PubMed ID: 8194658
[TBL] [Abstract][Full Text] [Related]
14. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.
Sugihara S; Sakamaki T; Konda S; Murata A; Wataki K; Kobayashi Y; Minamitani K; Miyamoto S; Sasaki N; Niimi H
Diabetes; 1997 Nov; 46(11):1893-7. PubMed ID: 9356042
[TBL] [Abstract][Full Text] [Related]
15. GAD antibodies in IDDM in Thailand.
Rattarasarn C; Aguilar-Diosdado M; Soonthornpun S; Patarakijvanich N; Jaruratanasirikul S
Diabetes Care; 1996 Jun; 19(6):674-5. PubMed ID: 8725876
[No Abstract] [Full Text] [Related]
16. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.
Maioli M; Pes GM; Delitala G; Puddu L; Falorni A; Tolu F; Lampis R; Orrù V; Secchi G; Cicalò AM; Floris R; Madau GF; Pilosu RM; Whalen M; Cucca F
Eur J Endocrinol; 2010 Oct; 163(4):541-9. PubMed ID: 20603341
[TBL] [Abstract][Full Text] [Related]
17. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).
Bottazzo GF; Bosi E; Cull CA; Bonifacio E; Locatelli M; Zimmet P; Mackay IR; Holman RR
Diabetologia; 2005 Apr; 48(4):703-8. PubMed ID: 15765222
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
[TBL] [Abstract][Full Text] [Related]
19. Seroconversion of glutamic acid decarboxylase antibodies in a patient initially diagnosed as having type 2 diabetes mellitus.
Nagai T; Imamura M; Mori M
Intern Med; 2005 Apr; 44(4):299-302. PubMed ID: 15897639
[TBL] [Abstract][Full Text] [Related]
20. Presence of anti-pituitary antibodies and GAD antibodies in NIDDM and IDDM.
Kobayashi T; Yabe S; Kikuchi T; Kanda T; Kobayashi I
Diabetes Care; 1997 May; 20(5):864-6. PubMed ID: 9135957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
